Rapid optimization and prototyping for therapeutic antibody-like molecules-Reference-Cited by-同舟云学术

Rapid optimization and prototyping for therapeutic antibody-like molecules

Published:2013-03 Issue:2 Volume:5 Page:237-254
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Xu Lihui,Kohli Neeraj,Rennard Rachel,Jiao Yang,Razlog Maja,Zhang Kathy,Baum Jason,Johnson Bryan,Tang Jian,Schoeberl Birgit,Fitzgerald Jonathan,Nielsen Ulrik,Lugovskoy Alexey A.

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/mabs.23363

Reference63 articles.

1. New Strategies in Head and Neck Cancer: Understanding Resistance to Epidermal Growth Factor Receptor Inhibitors

2. Targeting Multiple Kinase Pathways: A Change In Paradigm: Fig. 1.

3. Recombinant approaches to IgG-like bispecific antibodies

4. Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM×anti-CD3) as a targeted cancer immunotherapy

5. A new generation of protein display scaffolds for molecular recognition

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties;mAbs;2023-01-11

2. Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumors;mAbs;2021-01-01

3. Toward Drug-Like Multispecific Antibodies by Design;International Journal of Molecular Sciences;2020-10-12

4. Inhibition of Tumor Cell Growth and Cancer Stem Cell Expansion by a Bispecific Antibody Targeting EGFR and HER3;Molecular Cancer Therapeutics;2020-05-19

5. Antibody-mediated targeting of TNFR2 activates CD8 + T cells in mice and promotes antitumor immunity;Science Translational Medicine;2019-10-02